Aeterna Zentaris (NASDAQ:AEZS) Research Coverage Started at StockNews.com
StockNews.com assumed coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a research report released on Sunday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright lowered their price objective on Aeterna Zentaris from $28.00 to $15.00 and set a buy rating on the stock in […]